ACRV

Acrivon Therapeutics, Inc. Common Stock

1.75

USD

ACRV Earnings Reports

Positive Surprise Ratio

ACRV beat 10 of 12 last estimates.

83%

Next Report

Date of Next Report

Mar 24, 2026

Estimate for Q4 25 (Revenue/ EPS)

$197.20K

-$0.48

Implied change from Q3 25 (Revenue/ EPS)

+2.13%

Implied change from Q4 24 (Revenue/ EPS)

-20.00%

Acrivon Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, ACRV reported earnings of -0.47 USD per share (EPS) for Q3 25, beating the estimate of -0.60 USD, resulting in a 21.90% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.21% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.48 USD, with revenue projected to reach 197.20 thousand USD, implying an increase of 2.13% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Acrivon Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Acrivon Therapeutics, Inc. Common Stock reported EPS of -$0.47, beating estimates by 21.9%, and revenue of $0.00, 0% as expectations.

How did the market react to Acrivon Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 8.21%, changed from $2.07 before the earnings release to $2.24 the day after.

When is Acrivon Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 24, 2026.

What are the forecasts for Acrivon Therapeutics, Inc. Common Stock's next earnings report?

Based on 10 analysts, Acrivon Therapeutics, Inc. Common Stock is expected to report EPS of -$0.48 and revenue of $197.20K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.